HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ?
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
Hepcifer Trial is designed to assess the value of iv iron administration immediately after
liver surgery and consequences of inflammation on iron balance. Fifty patients will be
randomized in two treatment groups. Patients will be assigned to receive either iv iron or
placebo immediately after liver resection surgery. Biological inflammation parameters,
hemoglobin, serum iron and hepcidin levels will be assessed prior to surgery and at day 1, 3,
7, 15 and 30 after surgery.